Smokeless tobacco and risk of head and neck cancer: Evidence from a case-control study in New England

International Journal of Cancer

Volumn 132, Issue 8, 2013, Pages 1911-1917

  Zhou, Jiachen ^a   Michaud, Dominique S ^a,b   Langevin, Scott M ^a   McClean, Michael D ^c   Eliot, Melissa ^a   Kelsey, Karl T ^a  

^a BROWN UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

case control; head and neck cancer; smokeless tobacco

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNX; MALE; MOUTH CAVITY; PHARYNX; POPULATION BASED CASE CONTROL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKELESS TOBACCO; SMOKING HABIT; TUMOR LOCALIZATION; UNITED STATES;

AGED; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEW ENGLAND; RISK FACTORS; TOBACCO, SMOKELESS;

EID: 84873991336     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27839     Document Type: Article

References (28)

1. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856 Findings). Substance Abuse and Mental Health Services Administration, 2010.
2. McClave A, Rock V, Thorne S, et al. State-specific prevalence of cigarette smoking and smokeless tobacco use among adults-United States, 2009. JAMA-J Am Med Assoc 2011; 305: 143-46.
3. Tomar SL,. Trends and patterns of tobacco use in the United States. Am J Med Sci 2003; 326: 248-54.
4. Cullen JW, Blot W, Henningfield J, et al. Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General. Public Health Rep 1986; 101: 355-73.
5. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2007; 89: 1-592.
6. National Cancer Institute fact sheet smokeless tobacco and cancer, vol. 2010. Bethesda, MD: National Cancer Institute, 2010, http://www.cancer.gov/ cancertopics/factsheet/Tobacco/smokeless. Accesed on: September 26, 2012.
7. Winn DM, Blot WJ, Shy CM, et al. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981; 304: 745-9.
8. Stockwell HG, Lyman GH,. Impact of smoking and smokeless tobacco on the risk of cancer of the head and neck. Head Neck Surg 1986; 9: 104-10.
9. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7.
10. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998; 82: 1367-75.
11. Schildt EB, Eriksson M, Hardell L, et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 1998; 77: 341-6.
12. Boffetta P, Aagnes B, Weiderpass E, et al. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005; 114: 992-5.
13. Henley SJ, Thun MJ, Connell C, et al. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005; 16: 347-58.
14. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369: 2015-20.
15. Kabat GC, Chang CJ, Wynder EL,. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol 1994; 23: 1137-44.
16. Mashberg A, Boffetta P, Winkelman R, et al. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993; 72: 1369-75.
17. Bohlke K, Harlow BL, Cramer DW, et al. Evaluation of a population roster as a source of population controls: the Massachusetts Resident Lists. Am J Epidemiol 1999; 150: 354-8.
18. Edge SB, American Joint Committee on Cancer. AJCC cancer staging manual, 7th edn. New York: Springer, 2010.
19. Boffetta P, Hecht S, Gray N, et al. Smokeless tobacco and cancer. Lancet Oncol 2008; 9: 667-75.
20. Hecht SS, Rivenson A, Braley J, et al. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res 1986; 46: 4162-6.
21. Warnakulasuriya KA, Ralhan R,. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco-a review. J Oral Pathol Med 2007; 36: 63-77.
22. Stepanov I, Jensen J, Hatsukami D, et al. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006; 8: 309-13.
23. Administration SAaMHS. Results from the 2009 National Survey on drug use and health: Volume I. Summary of national findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4856 Findings), 2010.
24. Gartner CE, Hall WD, Vos T, et al. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007; 369: 2010-4.
25. Rodu B, Godshall WT,. Tobacco harm reduction: an alternative cessation strategy for inveterate smokers. Harm Reduct J 2006; 3: 37-60.
26. Stratton K, Shetty P, Wallace R, et al. Clearing the smoke: the science base for tobacco harm reduction-executive summary. Tob Control 2001; 10: 189-95.
27. Applebaum KM, Furniss CS, Zeka A, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst 2007; 99: 1801-10.
28. Peters ES, McClean MD, Marsit CJ, et al. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 2196-202.